| The genetic landscape of endometrial clear cell carcinomas DF DeLair, KA Burke, P Selenica, RS Lim, SN Scott, S Middha, ... The Journal of pathology 243 (2), 230-241, 2017 | 223 | 2017 |
| Method and apparatus to diagnose the metastatic or progressive potential of cancer, fibrosis and other diseases EB Brown III, SW Perry, KA Burke, RM Kottmann, PJ Sime, JW Sharp US Patent 10,765,376, 2020 | 210 | 2020 |
| Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results JC Byrd, WG Wierda, A Schuh, S Devereux, JM Chaves, JR Brown, ... Blood, The Journal of the American Society of Hematology 135 (15), 1204-1213, 2020 | 189 | 2020 |
| The landscape of somatic genetic alterations in metaplastic breast carcinomas CKY Ng, S Piscuoglio, FC Geyer, KA Burke, F Pareja, CA Eberle, RS Lim, ... Clinical cancer research 23 (14), 3859-3870, 2017 | 152 | 2017 |
| Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples LG Martelotto, T Baslan, J Kendall, FC Geyer, KA Burke, L Spraggon, ... Nature medicine 23 (3), 376-385, 2017 | 138 | 2017 |
| Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ... Nature communications 9 (1), 1816, 2018 | 132 | 2018 |
| Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene … S Piscuoglio, CKY Ng, M Murray, KA Burke, M Edelweiss, FC Geyer, ... The Journal of pathology 238 (4), 508-518, 2016 | 128 | 2016 |
| IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity S Chiang, B Weigelt, HC Wen, F Pareja, A Raghavendra, LG Martelotto, ... Cancer research 76 (24), 7118-7129, 2016 | 120 | 2016 |
| Second harmonic generation reveals matrix alterations during breast tumor progression K Burke, P Tang, E Brown Journal of biomedical optics 18 (3), 031106-031106, 2013 | 118 | 2013 |
| HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer X Xu, C De Angelis, KA Burke, A Nardone, H Hu, L Qin, J Veeraraghavan, ... Clinical Cancer Research 23 (17), 5123-5134, 2017 | 113 | 2017 |
| Uterine adenosarcomas are mesenchymal neoplasms S Piscuoglio, KA Burke, CKY Ng, AD Papanastasiou, FC Geyer, ... The Journal of pathology 238 (3), 381-388, 2016 | 105 | 2016 |
| The Antidepressant Desipramine and α2-Adrenergic Receptor Activation Promote Breast Tumor Progression in Association with Altered Collagen Structure MJ Szpunar, KA Burke, RP Dawes, EB Brown, KS Madden Cancer Prevention Research 6 (12), 1262-1272, 2013 | 99 | 2013 |
| Compromised BRCA1–PALB2 interaction is associated with breast cancer risk TK Foo, M Tischkowitz, S Simhadri, T Boshari, N Zayed, KA Burke, ... Oncogene 36 (29), 4161-4170, 2017 | 95 | 2017 |
| Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing … MF Rimawi, C De Angelis, A Contreras, F Pareja, FC Geyer, KA Burke, ... Breast cancer research and treatment 167, 731-740, 2018 | 91 | 2018 |
| Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer N Fusco, FC Geyer, MR De Filippo, LG Martelotto, CKY Ng, S Piscuoglio, ... Modern Pathology 29 (11), 1292-1305, 2016 | 85 | 2016 |
| Mutation profiling of key cancer genes in primary breast cancers and their distant metastases WAME Schrijver, P Selenica, JY Lee, CKY Ng, KA Burke, S Piscuoglio, ... Cancer research 78 (12), 3112-3121, 2018 | 76 | 2018 |
| Enzymatically-responsive pro-angiogenic peptide-releasing poly (ethylene glycol) hydrogels promote vascularization in vivo AH Van Hove, K Burke, E Antonienko, E Brown III, DSW Benoit Journal of Controlled Release 217, 191-201, 2015 | 76 | 2015 |
| Genomic and transcriptomic heterogeneity in metaplastic carcinomas of the breast S Piscuoglio, CKY Ng, FC Geyer, KA Burke, CF Cowell, LG Martelotto, ... NPJ breast cancer 3 (1), 48, 2017 | 72 | 2017 |
| The genetic landscape of breast carcinomas with neuroendocrine differentiation C Marchiò, FC Geyer, CKY Ng, S Piscuoglio, MR De Filippo, M Cupo, ... The Journal of pathology 241 (3), 405-419, 2017 | 65 | 2017 |
| Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways F Pareja, FC Geyer, R Kumar, P Selenica, S Piscuoglio, CKY Ng, ... NPJ Breast Cancer 3 (1), 40, 2017 | 58 | 2017 |
